10:40am ET
Health and Healthcare
Big Biotechs Scare Off Short Sellers
The April 30 short interest data have been compared with the previous report, and short interest in most of the selected biotech stocks decreased.
Companies
/Healthcare
AMGEN Inc
$377.35
▼ $5.12 (−1.34%) today
Markets closed · 6:11pm ET
AMGN Coverage
Page 19
8:40am ET
Health and Healthcare
The Top Biopharma Catalysts Coming in May
Here 24/7 Wall St. has included a calendar of some of the biggest companies expecting clinical trial and FDA updates in May.
8:40am ET
Health and Healthcare
Major Biotechs Face Rising Tide of Short Interest
The April 13 short interest data have been compared with the previous report, and short interest in most of the selected biotech stocks increased.
10:15am ET
Health and Healthcare
Eli Lilly, Amgen and More Big Pharma Earnings to Look For This Week
24/7 Wall St. has put together a preview of AbbVie, Eli Lilly and some of the other top pharma and biotech companies reporting their latest quarterly results in the coming week.
11:35am ET
Health and Healthcare
Will a Recent Rheumatoid Arthritis Drug Approval See Rekindled Interest?
Rheumatoid arthritis is an autoimmune disease that attacks tissues within the joints, and it is a major target of U.S. and foreign biotechnology and pharmaceutical companies.
9:05am ET
Health and Healthcare
Short Sellers Back Way Off Major Biotechs
The March 29 short interest data have been compared with the previous report, and short interest in most of the selected biotech stocks decreased.
9:30am ET
Health and Healthcare
Major Biotechs See Rising Tide in Short Interest
The March 15 short interest data have been compared with the previous report, and short interest in most of the selected biotech stocks increased.
7:55am ET
Health and Healthcare
Even More Biopharma Catalysts Coming Through the End of March
Here, 24/7 Wall St. has included a calendar of some of the biggest companies expecting clinical trial and FDA updates for the rest of March.
9:45am ET
Health and Healthcare
Major Biotechs: Tough Call for Short Sellers
The February 28 short interest data have been compared with the previous report, and short interest moves in the selected biotech stocks were mixed.
8:40am ET
Health and Healthcare
Major Biopharma Catalysts and FDA Events to Look For in March
24/7 Wall St. includes a calendar of a few of the biggest companies expecting clinical trial and FDA updates in the month of March.
9:15am ET
Health and Healthcare
Major Biotechs Continue to See a Rising Tide of Short Interest
The short interest data are out for the most recent settlement date, February 15. Generally speaking, companies within the biotech industry are considered to be a riskier group of stocks, with big…
8:40am ET
Investing
Jefferies Has 5 Stocks to Buy That Should Raise Dividends and Earnings
These five stocks come with upward earnings revisions and the potential for rising dividends. They all make good sense for investors looking for stocks ideas as we get closer to the second…
8:10am ET
Health and Healthcare
Top Analyst Has 3 Large Cap Biotechs to Buy as Massive Selling Subsides
With indiscriminate selling absolutely punishing some of the top large cap biotech stocks, one analyst says now is the time to buy.
9:15am ET
Health and Healthcare
Major Biotechs See Rising Tide of Short Interest
The January 31 short interest data have been compared with the previous report, and short interest in most of the selected biotech stocks increased.
9:15am ET
Investing
Top Analyst Upgrades and Downgrades: Amgen, Boeing, Chevron, Exxon, Foot Locker, Lowe’s, Nokia, PayPal, Sprint, Wells Fargo and More
The top analyst upgrades, downgrades and other research calls from Monday include Amgen, Boeing, Chevron, Exxon Mobil, Foot Locker, Lowe's, Nokia, PayPal, Sprint and Wells Fargo.